Evidence map›Paper›PMID 29630692›Full record

ArticleJAMA pediatrics2018

Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.

Claudia Lugo-Candelas, Jiook Cha, Susie Hong, Vanessa Bastidas, Myrna Weissman, William P Fifer, Michael Myers, Ardesheer Talati, Ravi Bansal, Bradley S Peterson and 3 more

Abstract readMulticenter Study
In one paragraph

Article in JAMA pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Trial
  4. Trial
  5. Trial
  6. Prenatal serotonin reuptake inhibitor exposure and maternal depression symptoms are associated with altered fetal brain and placental development.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Chronic dizziness: neuro-sensitization and psycho-sensitization.Frontiers in integrative neuroscience · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Claudia Lugo-CandelasDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Jiook ChaDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Susie HongDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Vanessa BastidasDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Myrna WeissmanDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
William P FiferDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Michael MyersDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Ardesheer TalatiDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Ravi BansalDepartment of Pediatrics, Keck School of Medicine, Los Angeles, California.
Bradley S PetersonDepartment of Pediatrics, Keck School of Medicine, Los Angeles, California.
Catherine MonkDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Jay A GingrichDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Jonathan PosnerDepartment of Psychiatry, Columbia University Medical Center, New York, New York.

Funding

Serotonergic Modulation of Brain Development: Genetic and Pharmacologic InfluencP50MH090966 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI WEISSMAN, MYRNA M · 2010 to 2014
$9.6M
Serotonin and the Modulation of Brain DevelopmentR01MH080116 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI GINGRICH, JAY A · 2008 to 2022
$5.3M
Neural Correlates of Fear Over-Generalization in Youth with Pathological AnxietyK01MH109836 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CHA, JIOOK · 2016 to 2019
$737k
NIMH NIH HHS K01 MH109836NIMH NIH HHS P50 MH090966NIMH NIH HHS R01 MH080116
6 · The paper itself

Abstract

Importance: Selective serotonin reuptake inhibitor (SSRI) use among pregnant women is increasing, yet the association between prenatal SSRI exposure and fetal neurodevelopment is poorly understood. Animal studies show that perinatal SSRI exposure alters limbic circuitry and produces anxiety and depressive-like behaviors after adolescence, but literature on prenatal SSRI exposure in humans is limited and mixed. Objective: To examine associations between prenatal SSRI exposure and brain development using structural and diffusion magnetic resonance imaging (MRI). Design, Setting, and Participants: A cohort study conducted at Columbia University Medical Center and New York State Psychiatric Institute included 98 infants: 16 with in utero SSRI exposure, 21 with in utero untreated maternal depression exposure, and 61 healthy controls. Data were collected between January 6, 2011, and October 25, 2016. Exposures: Selective serotonin reuptake inhibitors and untreated maternal depression. Main Outcomes and Measures: Gray matter volume estimates using structural MRI with voxel-based morphometry and white matter structural connectivity (connectome) using diffusion MRI with probabilistic tractography. Results: The sample included 98 mother (31 [32%] white, 26 [27%] Hispanic/Latina, 26 [27%] black/African American, 15 [15%] other) and infant (46 [47%] boys, 52 [53%] girls) dyads. Mean (SD) age of the infants at the time of the scan was 3.43 (1.50) weeks. Voxel-based morphometry showed significant gray matter volume expansion in the right amygdala (Cohen d = 0.65; 95% CI, 0.06-1.23) and right insula (Cohen d = 0.86; 95% CI, 0.26-1.14) in SSRI-exposed infants compared with both healthy controls and infants exposed to untreated maternal depression (P < .05; whole-brain correction). In connectome-level analysis of white matter structural connectivity, the SSRI group showed a significant increase in connectivity between the right amygdala and the right insula with a large effect size (Cohen d = 0.99; 95% CI, 0.40-1.57) compared with healthy controls and untreated depression (P < .05; whole connectome correction). Conclusions and Relevance: Our findings suggest that prenatal SSRI exposure has an association with fetal brain development, particularly in brain regions critical to emotional processing. The study highlights the need for further research on the potential long-term behavioral and psychological outcomes of these neurodevelopmental changes.

Indexed as

AdolescentAdultBrainDepressionDiffusion Magnetic Resonance ImagingFemaleFollow-Up StudiesGestational AgeHumansInfantInfant, NewbornMaleMaternal ExposureMiddle AgedOrgan SizePregnancySelective Serotonin Reuptake Inhibitors

Identifiers

PMID29630692
PMCPMC6137537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.